Please login to the form below

Not currently logged in
Email:
Password:

Gossamer Bio

This page shows the latest Gossamer Bio news and features for those working in and with pharma, biotech and healthcare.

Novartis ditches oral asthma drug after disappointing phase 3 readout

Novartis ditches oral asthma drug after disappointing phase 3 readout

The failure of Novartis’ drug also damages the overall hypothesis of DP2 targeting drug candidates, and particularly hurts the prospects of would-be competitor Gossamer Bio. ... If it can disprove the naysayers and bring GB001 to market in asthma,

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...